Clinical Trial Update: Study of Telaprevir in Subjects With Hepatic Impairment [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating telaprevir in subjects with hepatic impairment to assess pharmacokinetics and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED